Anup K. Khatana, M.D.
- Posted on: Jul 17 2013
Anup Khatana, MD grew up in Detroit, Michigan, completed his undergraduate, medical school and Ophthalmology Residency training at Wayne State University, Kresge Eye Institute Department of Ophthalmology. He served as Chief Resident during his last year at Kresge Eye Institute, and then completed a Glaucoma Fellowship at Wills Eye Hospital in Philadelphia before receiving Board Certification from the American Board of Ophthalmology.
Dr. Khatana joined Cincinnati Eye Institute (CEI) as a cataract and glaucoma specialist in 2000 and was named Director of the Glaucoma Service in 2012. He serves on CEI’s board of directors, chairs CEI’s physician recruitment committee, and is the Director of Glaucoma Fellowship. He is a Volunteer Clinical Professor at the University of Cincinnati College of Medicine, Department of Ophthalmology, and was voted teacher of the year by his residents here in 2011. He has been selected by his peers to Best Doctors in America since 2001.
Before joining CEI, he spent four years in Kansas City, dividing his time between private practice and academics, serving as Director of the Glaucoma Service and Clinical Assistant Professor of Ophthalmology at the Eye Foundation of Kansas City and University of Missouri-Kansas City School of Medicine. He was honored as teacher of the year by his residents there in 1999.
Dr. Khatana uses the latest cataract surgical technology to provide the best visual outcomes for patients. He also specializes in the management of various complicated and advanced forms of glaucoma, as well as all of the newer minimally invasive glaucoma surgeries. As an investigator in various clinical trials, Dr. Khatana is able to provide his patients access to new drugs and technologies at an earlier stage.
Glaucoma is often referred to as the “sneak thief” of sight because the most common types of glaucoma do not cause any symptoms until the optic nerve has significant damage. Glaucoma is actually a complex group of disorders that all produce a similar and typical pattern of optic nerve fiber death resulting in typical patterns of loss of the field of vision.
Because glaucoma kills optic nerve fibers, early diagnosis is critical. CEI has the latest in visual field and optic nerve testing technology that aids in early detection. The first line of therapy for glaucoma is usually eye drops to lower the intraocular pressure. There are also several different laser procedures that have proven effective in fighting glaucoma.
For patients who cannot be controlled with medical or laser therapy, there are now several surgical options to treat glaucoma, and these can often be combined with the latest cataract surgical techniques. CEI is proud to be able to offer our patients every currently approved glaucoma laser and surgery.
He is a member of the American Academy of Ophthalmology and the American Glaucoma Society. Dr. Khatana sees patients at the Blue Ash office in Cincinnati.
Outside of medicine, Dr. Khatana enjoys a variety of music, movies, tennis, skiing, and spending time with his family.